Your browser doesn't support javascript.
loading
Tumor hypoxia: an important regulator of tumor progression or a potential modulator of tumor immunogenicity?
Hassan Venkatesh, Goutham; Abou Khouzam, Raefa; Shaaban Moustafa Elsayed, Walid; Ahmed Zeinelabdin, Nagwa; Terry, Stéphane; Chouaib, Salem.
Afiliação
  • Hassan Venkatesh G; Thumbay Research Institute for Precision Medicine, Gulf Medical University, Ajman, United Arab Emirates.
  • Abou Khouzam R; Thumbay Research Institute for Precision Medicine, Gulf Medical University, Ajman, United Arab Emirates.
  • Shaaban Moustafa Elsayed W; College of Dentistry, Gulf Medical University, Ajman, United Arab Emirates.
  • Ahmed Zeinelabdin N; Thumbay Research Institute for Precision Medicine, Gulf Medical University, Ajman, United Arab Emirates.
  • Terry S; Inserm Umr 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Faculty of Medicine, University Paris-Saclay, Villejuif, France.
  • Chouaib S; Thumbay Research Institute for Precision Medicine, Gulf Medical University, Ajman, United Arab Emirates.
Oncoimmunology ; 10(1): 1974233, 2021.
Article em En | MEDLINE | ID: mdl-34595058

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipóxia Tumoral / Processos Neoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipóxia Tumoral / Processos Neoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article